Congestive Heart Failure Clinical Trial
Official title:
Quality of Life Measures After Mitral Valve Repair in Non-Ischaemic Cardiomyopathy
- Chronic severe mitral regurgitation can lead to symptoms and left ventricular
dysfunction.
- The purpose of this study is to prospectively follow patients with non-ischaemic
cardiomyopathy who are eligible for mitral valve repair surgery and primarily measure
the quality of life through the Minnesota Living with Heart Failure Questionnaire & the
Kansas City Cardiomyopathy Questionnaire.
- Chronic mitral regurgitation (MR) usually spirals into a vicious cycle of left
ventricular (LV) volume overload, LV dilatation, mitral annular dilatation and more MR.
"MR begets MR". Eventually symptoms and LV dysfunction ensue. However, it can often be
treated medically or surgically. Medical therapy is primarily afterload reduction and
diuretics. Surgically, there are two options, either mitral valve repair or replacement.
- A number of retrospective studies have demonstrated improved LV function and survival in
patients undergoing valve repair compared to valve replacement with or without
subvalvular preservation. In one report, for example, patients who underwent valve
repair were compared to patients who underwent valve replacement. The report found that
the former group had lower operative mortality, a greater increase in LV ejection
fraction and higher overall ten year survival.
- The bulk of the literature at present addresses left ventricular dimensions, ejection
fraction, geometry and New York Heart Association functional class, but few have
addressed quality of life measures. In addition, most of these studies were
retrospective and the majority of patients had concomitant ischaemic heart disease.
- Even though the studies concerning quality of life after mitral valve surgery have been
few, nevertheless, some have addressed isolated valve surgery without concomitant bypass
surgery and have shown improved quality of life, though follow up in some was limited to
3 months. We will follow our population for 12 months after surgical repair.
- We will primarily look at subjective measures for quality of life such as the Minnesota
Living with Heart Failure Questionnaire & the Kansas City Cardiomyopathy Questionnaire,
as subjective measures are becoming more and more important following cardiac surgery.
Patients will serve as their own controls and all study parameters will be compared pre-
and post surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Recruiting |
NCT04703842 -
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
|
Phase 1/Phase 2 | |
Terminated |
NCT05594940 -
Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility Study
|
||
Recruiting |
NCT04982081 -
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
|
Phase 1 | |
Completed |
NCT04394754 -
Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure
|
N/A | |
Active, not recruiting |
NCT01385176 -
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
|
N/A | |
Not yet recruiting |
NCT05516290 -
Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure
|
||
Terminated |
NCT02788656 -
Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
|
Phase 4 | |
Completed |
NCT02885636 -
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
|
Phase 3 | |
Terminated |
NCT02205411 -
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
|
N/A | |
Completed |
NCT02252757 -
Assess Measurements of Wireless Cardiac Output Device
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Withdrawn |
NCT00346177 -
Stem Cell Study for Patients With Heart Failure
|
Phase 2 | |
Active, not recruiting |
NCT01058837 -
SCD-HeFT 10 Year Follow-up
|
N/A | |
Completed |
NCT00957541 -
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
|
Phase 2 |